Logo

Gastrointestinal

News on in vitro diagnostics for gastrointestinal disease.

Castle Biosciences Buy of Cernostics Aligns With Goal to Diversify Portfolio
Premium

The acquisition of Cernostics and its TissueCypher Barrett's Esophagus Assay provides a route for Castle to enter gastrointestinal testing.

Genetic Analysis Raises $6.8M in Oversubscribed IPO

The Norwegian microbiome diagnostic company's stock closed up 50 percent after two days of trading on the Swedish Spotlight Stock Market.

Norway's Genetic Analysis Hopes HumGut Database Will Spawn New Diagnostics, Therapies
Premium

In particular, the diagnostics company expects the new resource to strengthen its offerings to pharmaceutical partners, a key customer group.

Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test

Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device.

Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics
Premium

The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end.

Mar 12, 2021

Prometheus Biosciences Prices Upsized $190M IPO

Jan 19, 2021

ABO Histo-Blood Groups Influence Makeup of Gut Microbiome, New Study Finds

Dec 8, 2020

Single-Cell Transcriptome Study Links Gut Development, Pediatric Crohn's Disease

Sep 2, 2020

BiomX, Boehringer Ingelheim Partner for Inflammatory Bowel Disease Biomarker Discovery

Aug 12, 2020

Traveler's Diarrhea Among Soldiers Linked to Gut Microbiome Changes

Jul 10, 2020

Infant Gut Microbiome Correlates With Bacteria in Mother's Breast Milk, Study Finds

Jun 19, 2020

Progenity Prices $100M IPO at $15 per Share

Mar 5, 2020

Genedata Moves Into R&D for Nonprofits, Adds Digital Pathology Support
Premium

Nov 7, 2019

PredictImmune, Crohn's & Colitis Foundation Collaborate on IBD Test Validation Study

Oct 28, 2019

Theradiag to Commercialize PredictImmune IBD Test in French-Speaking Europe and Africa

Sep 4, 2019

uBiome Declares Bankruptcy, Offers Assets for Sale

Jun 18, 2019

Mayo Clinic Spinout Developing Multiomics Blood Test to Identify Obesity Phenotypes
Premium

Apr 19, 2019

Active Celiac Disease Processes Informed by Intestinal Expression Comparison

Apr 18, 2019

Pancreatic, Brain Development Gene Found From Patient Exomes

Apr 11, 2019

Hirschsprung's Disease Genetic Analysis Reveals Mix of Common, Rare Risk Variants

Mar 6, 2019

Inflammatory Bowel Disease Transcriptome Analysis Finds Increased Levels of SERPINE1

Feb 26, 2019

New IBD Adverse Drug Response Risk Gene Identified

Feb 19, 2019

Australia's Microba Taps Google Cloud for Human Gut Microbiome Data Processing
Premium

Feb 4, 2019

Gut Microbe Studies Expand Bacterial Culture Collections, Reference Genomes

Jan 24, 2019

Meridian Fiscal Q1 Revenues Down 2 Percent

Breaking News
The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.